Medivation Announces Participation at Upcoming Investor Conferences
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 10/30/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:
David Hung, M.D., president and chief executive officer, will present at the Credit Suisse Healthcare Conference on Wednesday, November 13 at 1:30pm at the Phoenician Hotel in Scottsdale, AZ.
David Hung, M.D., president and chief executive officer, will present at the Jefferies 2013 London Healthcare Conference on Wednesday, November 20 at 2:20 pm at the Waldorf Hilton in London.
Individuals may access the live audio webcast by visiting: . A replay of the webcast will be available on the Company's website for 30 days following the live event.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at .
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.10.2013 - 15:30 Uhr
Sprache: Deutsch
News-ID 1277826
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN FRANCISCO, CA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 121 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Announces Participation at Upcoming Investor Conferences
"
steht unter der journalistisch-redaktionellen Verantwortung von
Medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
